Pharmacokinetic-pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT 1A receptor agonist flesinoxan

By Zuideveld K.P.   van Gestel A.   Peletier L.A.   Van der Graaf P.H.   Danhof M.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 43-54

Elsevier

Access to resources Recommend Favorite

An integrative pharmacokinetic and pharmacodynamic study of the 5-HT 1A receptor antagonist (S)-UH-301 in the rat

By Yan H.   Yu H.   Lewander T.  

European Neuropsychopharmacology, Vol. 12, Iss. 2, 2002-04 ,pp. : 101-110

Elsevier

Access to resources Recommend Favorite

Population Pharmacokinetic-Pharmacodynamic Modelling of Angiotensin Receptor Blockade in Healthy Volunteers

By Csajka C.  

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 137-152

Adis International

Access to resources Recommend Favorite

Validation of a population pharmacokinetic/pharmacodynamic model for 5 -reductase inhibitors

By Trouw R.A.J.   De Wit M.J.   Olsson Gisleskog P.   Hermann D.   Hammarlund-Udenaes M.   Karlsson M.O.  

European Journal of Pharmaceutical Sciences, Vol. 8, Iss. 4, 1999-08 ,pp. : 291-299

Elsevier

Access to resources Recommend Favorite

The 5HT 1A receptor ligand, S15535, antagonises G-protein activation: a [ 35 S]GTP S and [ 3 H]S15535 autoradiography study

By Newman-Tancredi A.   Rivet J.-M.   Chaput C.   Touzard M.   Verriele L.   Millan M.J.  

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 111-121

Elsevier

Access to resources Recommend Favorite